Garadacimab (Synonyms: CSL312) |
| Catalog No.GC69151 |
Garadacimab (CSL312) is a first-in-class fully human IgG4 monoclonal antibody that targets activated factor XII (FXIIa). Garadacimab has the potential for use in research on hereditary angioedema.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2162134-62-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Garadacimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Garadacimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *